Association study of the GAB2 gene with the risk of developing Alzheimer's disease

Julien Chapuis, Didier Hannequin, Florence Pasquier, Peter Bentham, Alexis Brice, Isabelle Leber, Thierry Frebourg, Jean François Deleuze, Emmanuelle Cousin, Uma Thaker, Philippe Amouyel, David Mann, Corinne Lendon, Dominique Campion, Jean Charles Lambert

    Research output: Contribution to journalArticlepeer-review


    The first genome-wide association in Alzheimer's disease (AD) suggested that the GAB2 gene rs2373115 polymorphism may be a strong risk factor in APOE e{open}4-carriers. We failed to detect an association of rs2373115 with the risk of developing AD in three populations (totalling 1406 controls and 1749 AD cases) whatever the APOE status, even if we observed a slight tendency for an increase of the GG genotype (OR (GG versus GT + TT) = 1.3, 95% CI 1.0-1.6, p = 0.09) and the G allele frequency (OR = 1.3, 95%CI 1.0-1.6, p = 0.05) in e{open}4-carriers. In addition, the rs2373115 did not modulate the extent of tau phosphorylation in the brain of 89 AD cases. The GAB2 gene is at best a minor genetic determinant of AD. © 2008 Elsevier Inc. All rights reserved.
    Original languageEnglish
    Pages (from-to)103-106
    Number of pages3
    JournalNeurobiology of disease
    Issue number1
    Publication statusPublished - Apr 2008


    • Alzheimer
    • APOE
    • GAB2
    • Polymorphism


    Dive into the research topics of 'Association study of the GAB2 gene with the risk of developing Alzheimer's disease'. Together they form a unique fingerprint.

    Cite this